Cardiovascular and parasympathetic effects of dexmedetomidine in healthy subjects

Author： Penttilä Jani Helminen Antti Anttila Markku Hinkka Susanna Scheinin Harry

ISSN： 1205-7541

Source： Canadian Journal of Physiology and Pharmacology, Vol.82, Iss.5, 2004-05, pp. : 359-362

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CCK 4 -induced panic in healthy subjects I: psychological and cardiovascular effects

By Jerabek I. Boulenger J.-P. Bradwejn J. Lavallee Y.-J. B. Jolicoeur F.

European Neuropsychopharmacology, Vol. 9, Iss. 1, 1999-01 ,pp. : 149-155

Elsevier

Access to resources Recommend Favorite

Beat-to-Beat Measurement of Cardiovascular Effects of a Single Subcutaneous Dose of Terbutaline in Healthy Subjects

By Mulder W.M.C.

Clinical Drug Investigation, Vol. 22, Iss. 9, 2002-01 ,pp. : 593-600

Adis International

Access to resources Recommend Favorite

Autonomic Effects of Nebivolol versus Atenolol in Healthy Subjects

By Chiladakis John Georgiopoulou Ekaterini Alexopoulos Dimitrios

Cardiovascular Drugs and Therapy, Vol. 18, Iss. 6, 2004-11 ,pp. : 469-473

Springer Publishing Company

Access to resources Recommend Favorite

Bioavailability and Safety of the Factor Xa Inhibitor Edoxaban and the Effects of Quinidine in Healthy Subjects

Clinical Pharmacology In Drug Development, Vol. 2, Iss. 4, 2013-10 ,pp. : 358-366

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of Age, Sex, and Obesity on the Single‐Dose Pharmacokinetics of Omarigliptin in Healthy Subjects

Clinical Pharmacology In Drug Development, Vol. 5, Iss. 5, 2016-09 ,pp. : 374-382

John Wiley & Sons Inc

Access to resources Recommend Favorite